Amedisys (AMED) Tops Q4 EPS by 1c, Revs Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance
February 18, 2020 4:15 PM ESTBATON ROUGE, La., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2019.
Three Month Periods Ended December 31, 2019 and 2018
Net service revenue increased $66.3Â million to $500.7Â million compared to $434.4Â million in 2018.Net income attributable to Amedisys, Inc. of $27.7Â million compared to $27.5Â million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $0.83 compared to $0.84 in 2018.Adjusted Quarterly Results*
Adjusted EBITDA of $52.2Â million compared to $43.9Â million in 2018.Adjusted net service revenue of $500.7Â million compared to $434.4Â million in... More


